Detalles de la búsqueda
1.
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-443299
2.
CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-442538
3.
A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-441501
4.
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-477770
5.
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474307
6.
Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444010
7.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-437942
8.
A multispecific antibody confers pan-reactive SARS-CoV-2 neutralization and prevents immune escape
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-502029
9.
Broadly neutralizing antibodies target the coronavirus fusion peptide
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-487879
10.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-432969
11.
Convergent epitope specificities, V gene usage and public clones elicited by primary exposure to SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-486152
Resultados
1 -
11
de 11
1
Próxima >
>>